Bio-Thera Solutions is a clinical-stage biopharmaceutical company focused on innovative oncology therapeutics and biosimilars. Bio-Thera is developing a pipeline on antibody-drug conjugates and enhanced monoclonal antibodies for the treatment of a broad range of cancers and other diseases. Bio-Thera’s biosimilar pipeline is focused on autoimmune and oncology therapeutics. The company is headquartered in Guangzhou, China and has more than 300 employees.
